Mucormycosis drug AmphoTLC will be imported from Taiwan by Stelis Biopharma Private Limited (Stelis), the biotech arm of Strides group, and will be launched and distributed in India immediately by Strides
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Acquisition includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogram cells in vivo with potential best-in-class profile for autoimmune diseases
Element5’s Agentic AI platform will be integrated with the HCHB EHR
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Bayer expects 2025 to be the most difficult year of its turnaround
Subscribe To Our Newsletter & Stay Updated
